The US Food and Drug Administration (FDA) approved a VenaSeal closure system to permanently treat varicose veins in the legs. On Friday, the FDA said that it is the first treatment, which will involve the usage of an adhesive agent in order to cut off blood supply to affected veins.
Superficial varicose veins in the leg appear close to the skin. Although people with varicose veins experience no symptoms, some experience mild to moderate pain, blood clots, skin ulcers or other problems.
Also read: FDA approves first 2-drug HIV regimen